Antibiotic Use in Sub-Saharan Africa: Challenges and Strategies

By Crystal Lubbe

October 29, 2024

The article titled “Antibiotic prescription sources and use among under-5 children with fever/cough in sub-Saharan Africa” provides a critical analysis of antibiotic use and prescription sources for children under 5 with fever or cough in sub-Saharan Africa (SSA). In particular, this analysis sheds light on the significant issue of antibiotic misuse, thereby emphasising the necessity for appropriate interventions.

Methodology

The study used data from the Demographic and Health Surveys (DHS) from 2006 to 2021, covering 37 SSA countries and including 18,866 children under 5 with fever or cough.

Main Findings

Overall, the majority of children received antibiotics from unqualified sources, which highlights a significant issue with inappropriate use in the region. Moreover, the study identified that children with formally educated mothers were more likely to receive antibiotics from qualified sources. This finding stressed the vital role of maternal education in improving antibiotic prescription sources.

Implications and Recommendations

Consequently, these findings stress the need to address healthcare disparities, enhance access to qualified providers, and promote maternal education, to ensure proper antibiotic use. Moreover, there is an urgency for targeted interventions and policies to optimise antibiotic prescribing practices and combat AMR in sub-Saharan Africa.

Antimicrobial Resistance

The World Health Organization’s 2022 report highlights AMR as a leading cause of death, attributing 5 million deaths in 2019 to bacterial AMR. The United Nations warns that AMR can lead to 10 million deaths annually by 2050, resulting in severe economic consequences.

Gap in Existing Literature

The study addresses a gap by focusing on children under 5 with fever or cough in SSA. This population has often been overlooked in research, which typically focused on adults or limited simulations in a few countries.

Conclusion

The study offers insights into antibiotic prescription patterns and determinants for children under 5 in sub-Saharan Africa. This stresses the need for effective interventions to ensure proper antibiotic use and reduce antimicrobial resistance risks. Addressing these issues is vital for the health of children in the region.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.